Related by context. Frequent words. (Click for all words.) 67 addressing idiopathic pulmonary 66 Panzem R 66 fibrosis IPF 65 Inc Therapeutic Competitors 65 investigational compounds 64 * Azixa 64 Loramyc R 63 Eligard R 63 R bortezomib 63 Rebif ® 63 Therapeutic Competitors 62 MKC# 62 R sorafenib tablets 62 generation proteasome inhibitor 62 Exploit collaboration 62 Medarex logo 61 2 methoxyestradiol 61 PEG SN# 61 Fortical R 61 topical anti infective 61 QuatRx 61 includes investigational compounds 61 Mersana 61 Nanobody 61 FACTIVE R gemifloxacin 60 Receives Orphan Drug Designation 60 Nexavar ® 60 GVAX R 60 TREANDA 60 MEK inhibitors 60 developing Zerenex TM 60 Harbor BioSciences 60 VEGFR2 inhibitor 60 Panzem R NCD 60 liposomal formulation 60 PLAVIX R 60 Cetrorelix 60 proteasome inhibitor 59 Aloxi R 59 BioGlue R 59 Argatroban 59 Loramyc ® 59 Recombinant Human 59 preclinical compounds 59 Atrigel 59 Initiates Phase II 59 Eloxatin ® 59 AMRIX 59 vosaroxin 59 Transcept Pharmaceuticals 59 Altus Pharmaceuticals 59 Factor VIIa 59 Paladin Labs 59 ABILIFY R 59 SNALP 59 Inc. NASDAQ TRGT 59 Apricus Bio 59 AMITIZA R 59 cancer immunotherapies 59 deforolimus 59 Captisol 59 NYSE Amex RNN 59 DNA RNA Medicines 59 Ambrisentan 59 iFinix Trader 58 HepeX B 58 nitric oxide donating 58 ZEGERID R 58 Drug Candidate 58 Carfilzomib 58 Potassium Chloride Sodium Ascorbate 58 Visudyne R 58 Meets Primary Endpoint 58 GVAX cancer 58 CyDex 58 Mipomersen 58 BEMA Buprenorphine 58 Presents Positive 58 tezampanel 58 HCV protease inhibitor 58 Tesetaxel 58 Kuvan R 58 JAK inhibitor 58 THALOMID 58 oncology therapeutics 58 Entereg R 58 CDP# 58 Testim R 58 multi kinase inhibitor 58 WILEX 58 Release Tablets 58 Taiho Pharmaceutical 58 ATS 3f R 58 Ixempra 58 Dynogen 58 Pivotal Phase III 58 AMB invests 58 Hybridon 58 ProEthic 58 Generic Version 58 www.vivus.com